MRNY vs XXV

MRNYBYieldMax MRNA Option Income Strategy ETF

XXVASimplify Ancorato Target 25 Distribution ETF

In short

MRNY Moderna, but with a job. MRNY sells weekly call spreads on MRNA and routes the premium out as a monthly distribution, keeping room for some upside through the spread's long leg. You still carry the stock's downside, without owning the shares.

XXV Structured-note income without the bank. XXV sells barrier put options on single stocks, and sometimes worst-of baskets, chasing an aspirational 25% annualized payout, with the options rolled continuously. The top rung of Simplify's barrier-income ladder.

Stated mandate

MRNY MRNY is actively managed to generate weekly income by selling call spreads on Moderna Inc., while seeking participation in appreciation of the underlying share price.

XXV XXV seeks high monthly income through selling barrier put options referencing individual stocks, with possible use of worst-of baskets of individual stocks. Its 25% annualized distribution goal is aspirational and not guaranteed.

Why people hold it

• MRNY Charges 1.00% a year, below the typical fee in its single-stock option-income peer group.
• Sells call spreads rather than plain calls, so the long leg leaves room to participate in part of a Moderna rally instead of surrendering all of it.yieldmaxetfs.com
• Options are written weekly and cash goes out monthly, an actively managed rhythm built around one stock's premium.
• Live since 2023, one of the earlier single-stock income funds in a category that has since crowded to dozens of tickers.

• XXV 0.85% a year sits below the going rate in its single-stock options-income cohort, where peers like BRKC and TSMY run near 1%.
• Options are rolled automatically and continuously, and the ETF wrapper strips out the bank credit risk you take on with a traditional structured note.simplify.ussimplify.us 2
• Built around cash flow: barriers are adjusted to levels designed to support a 25% annualized distribution target, paid monthly.simplify.us
• Sub-advised by Ancorato Capital, a structured-products specialist, and one of the stronger implementations in a crowded options-income field.simplify.us

Worth knowing

• MRNY Synthetic exposure: you take Moderna's declines without holding the shares, and the short call caps how much of an advance the fund keeps.
• Payouts come from option premiums, which rise and fall with Moderna's option pricing. Monthly amounts vary rather than run at a set rate.
• The 1.00% fee buys the overlay and the active management, not a plain stake in the underlying stock.

• XXV Barriers cushion, they do not erase. Selling puts on single stocks means the fund wears the loss when a reference name breaks through its barrier.simplify.us
• The 25% figure is an aspirational goal, not a promise, and distributions may include return of capital, which is your own money coming back.
• Launched in late 2025 and thinly traded, so bid-ask spreads can cost more than the expense ratio on the way in and out.

Full MRNY profile⁠

Full XXV profile⁠